Crossmark

Evaluation of maSSS/maSES-PEG2-RM26 for their potential therapeutic use after labeling with Re-188. Could their [99mTc]Tc-labeled counterparts be used to estimate dosimetry?

Crossref DOI link: https://doi.org/10.1186/s41181-024-00326-3

Published Online: 2025-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kanellopoulos, Panagiotis https://orcid.org/0000-0002-0617-3936
Yu, Quanyi

Abouzayed, Abouzayed

Bezverkhniaia, Ekaterina

Tolmachev, Vladimir

Orlova, Anna
Funding

Funding for this research was provided by:

Uppsala University
License Information

Text and Data Mining valid from 2025-01-17

Version of Record valid from 2025-01-17
More Information

Article History

Received: 5 November 2024

Accepted: 19 December 2024

First Online: 17 January 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below